Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Enhertu bags EU approval for HER2-positive breast cancer

pharmatimesJanuary 21, 2021

Tag: Enhertu , AstraZeneca , Breast Cancer , EU , Daiichi Sankyo

PharmaSources Customer Service